AbbVie : ABBV

All AbbVie Articles

612 Articles

Lee Jackson | Nov 25, 2024 at 11:46 AM EST

One Sector Has Underperformed Massively: These 4 Blue-Chip Dividend Giants Are Huge 2025 Plays

Donald Trump’s victory is positive for the stock market. The healthcare sector has underperformed and offers enormous upside. Healthcare stocks…

Chris MacDonald | Nov 23, 2024 at 12:39 PM EST

Dividend Aristocrats Yielding Over 4% to Buy in November

Companies with high dividend yields are relatively uncommon in this market. In fact, the average yield on the S&P 500…

Rich Duprey | Nov 17, 2024 at 10:52 AM EST

Can This Dividend King Ever Hit $400 After This Major Fail?

24/7 Wall St. Insights: AbbVie (ABBV | ABBV Price Prediction) took a big hit after an adult schizophrenia drug missed…

Trey Thoelcke | Nov 16, 2024 at 9:10 AM EST

Dividend King AbbVie Just Paid Investors: Here’s How Much They Got

AbbVie has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady…

Joel South | Oct 15, 2024 at 9:59 AM EDT

Dividend Aristocrat AbbVie Just Paid Investors; Here’s How Much They Received

AbbVie Inc. (NYSE: ABBV) | ABBV Price Prediction is rewarding its shareholders once again with a quarterly dividend of $1.55,…

Chris MacDonald | Oct 3, 2024 at 8:11 AM EDT

3 Top Pharma Stocks to Buy in October 2024

The pharmaceutical industry plays a crucial role in most of our everyday lives. From life-saving medication we need when we…

Trey Thoelcke | Sep 19, 2024 at 9:15 AM EDT

Prediction: This Will Be the Biggest Pharma Stock in 10 Years

Eli Lilly is the clear frontrunner to be the largest pharmaceutical stock in 2034. See what the company's prospects are…

Rich Duprey | Sep 8, 2024 at 7:43 AM EDT

3 Crazy Stocks to Buy That Are Outperforming Nvidia in 2024

The release of OpenAI‘s ChatGPT chatbot in November 2022 unleashed a frenzy of investor interest in artificial intelligence that propelled…

Rich Duprey | Aug 27, 2024 at 10:19 AM EDT

2 Stocks to Buy Now Before a Stock Market Crash

A recession is looming. Despite the S&P 500 nearing its all-time high, the yield curve inverted and the Sahm Rule…

Lee Jackson | Aug 13, 2024 at 10:08 AM EDT

Prediction: Abbvie’s Dividend Payouts Will Increase in 2025

24/7 Wall St. Insights Stocks that consistently raise their dividends offer investors huge total return potential. Dividend stocks will become…

Jacob Wolinsky | Aug 8, 2024 at 2:05 PM EDT

3 Passive Income Dividend Stocks To Buy Now

Dividend stocks can provide investors with passive long-term income. AbbVie offers stable and consistent distributions. Realty Income has increased its…

Lee Jackson | Jul 30, 2024 at 11:20 AM EDT

5 Dividend Aristocrats May Be Primed for a Big August

24/7 Insights Dividend Aristocrat shareholders could see some big upside in August. Looking at quality stocks that pay dependable quarterly…

Lee Jackson | Jul 11, 2024 at 10:27 AM EDT

5 High-Yield Dividend Champions to Buy Hand Over Fist Now

Dividend stocks are a favorite among investors for good reasons. They provide a steady income stream and offer a promising…

Trey Thoelcke | Jul 4, 2024 at 9:15 AM EDT

Eli Lilly Stock Price Prediction: Where Will It Be in 1 Year

Wall Street expectations for where Eli Lilly stock is headed this year vary considerably, but some analysts still have faith.

Aaron Webber | May 11, 2024 at 9:30 AM EDT

Discover the Stocks the Political Elite Bought and Sold This Month

It defies all reason that elected officials are allowed to buy and sell stock in an economy that they are…

1 … 7 8 9 10 11 … 41

AbbVie : ABBV

All AbbVie Articles

One Sector Has Underperformed Massively: These 4 Blue-Chip Dividend Giants Are Huge 2025 Plays

Dividend Aristocrats Yielding Over 4% to Buy in November

Can This Dividend King Ever Hit $400 After This Major Fail?

Dividend King AbbVie Just Paid Investors: Here’s How Much They Got

Dividend Aristocrat AbbVie Just Paid Investors; Here’s How Much They Received

3 Top Pharma Stocks to Buy in October 2024

Prediction: This Will Be the Biggest Pharma Stock in 10 Years

3 Crazy Stocks to Buy That Are Outperforming Nvidia in 2024

2 Stocks to Buy Now Before a Stock Market Crash

Prediction: Abbvie’s Dividend Payouts Will Increase in 2025

3 Passive Income Dividend Stocks To Buy Now

5 Dividend Aristocrats May Be Primed for a Big August

5 High-Yield Dividend Champions to Buy Hand Over Fist Now

Eli Lilly Stock Price Prediction: Where Will It Be in 1 Year

Discover the Stocks the Political Elite Bought and Sold This Month

Korean Chip Stocks Are Trading Like The AI Bubble Has Burst. Is Micron Next?

Price Prediction: ON Semiconductor’s Rally May Be Far From Over

Here’s Why GE Vernova Is a No-Brainer Buy Before July 22 Earnings

75-Year-Old With $1.3M Faces $58,000 RMD That Drags 85% of His Social Security Into Tax

The Real Risk in Retirement Isn't Running Out of Money. It's Losing Your Purchasing Power.

Korean Chip Stocks Are Trading Like The AI Bubble Has Burst. Is Micron Next?

Price Prediction: ON Semiconductor’s Rally May Be Far From Over

AbbVie : ABBV

All AbbVie Articles

One Sector Has Underperformed Massively: These 4 Blue-Chip Dividend Giants Are Huge 2025 Plays

Dividend Aristocrats Yielding Over 4% to Buy in November

Can This Dividend King Ever Hit $400 After This Major Fail?

Dividend King AbbVie Just Paid Investors: Here’s How Much They Got

Dividend Aristocrat AbbVie Just Paid Investors; Here’s How Much They Received

3 Top Pharma Stocks to Buy in October 2024

Prediction: This Will Be the Biggest Pharma Stock in 10 Years

3 Crazy Stocks to Buy That Are Outperforming Nvidia in 2024

2 Stocks to Buy Now Before a Stock Market Crash

Prediction: Abbvie’s Dividend Payouts Will Increase in 2025

3 Passive Income Dividend Stocks To Buy Now

5 Dividend Aristocrats May Be Primed for a Big August

5 High-Yield Dividend Champions to Buy Hand Over Fist Now

Eli Lilly Stock Price Prediction: Where Will It Be in 1 Year

Discover the Stocks the Political Elite Bought and Sold This Month

Korean Chip Stocks Are Trading Like The AI Bubble Has Burst. Is Micron Next?

Price Prediction: ON Semiconductor’s Rally May Be Far From Over

Here’s Why GE Vernova Is a No-Brainer Buy Before July 22 Earnings

Featured Reads

75-Year-Old With $1.3M Faces $58,000 RMD That Drags 85% of His Social Security Into Tax

The Real Risk in Retirement Isn't Running Out of Money. It's Losing Your Purchasing Power.